Latest Breaking News On - Fda approval of ide cel - Page 1 : comparemela.com

Krina K. Patel, MD, MSc, discusses the FDA approval of ide-cel for patients with triple class–exposed relapsed/refractory multiple myeloma.

United statesKrinak patelDepartment of lymphoma myelomaUniversity of texas md anderson cancer centerDivision of cancer medicineCancer medicineCancer centerFda approval of ide celPatients with triple class exposed relapsed refractory multiple myeloma